Payers' growing use of clinical pathways and the country's new focus on precision medicine are not mutually exclusive as long as the pathways are written properly, according to an American Medical Association board member and oncologist who stresses that such pathways need to be flexible and updated frequently or otherwise "you'll be practicing obsolete medicine." The AMA official also called for transparency, saying a patient needs to be aware if their doctor's "arm is being twisted" by a pathway. Her...